https://www.selleckchem.com/pr....oducts/oxalacetic-ac
To determine the rate of second primary lung cancer (SPLC) and describe the clinical characteristics and radiological findings in individuals with a prior history of cancer presenting to a low-dose computed tomography (LDCT) lung cancer screening program at a tertiary cancer center. Patients with a previous history of malignancy, a life expectancy ≥ 5years referred for CT lung cancer screening between May 2, 2011, and November 28, 2018, were included. Demographics regarding risk factors including smoking history and prior histor
Gefällt mir
Kommentar
Teilen
